BioHarvest Sciences Return on Tangible Equity 2020-2024 | BHST
Current and historical return on tangible equity values for BioHarvest Sciences (BHST) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| BioHarvest Sciences Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-06-30 |
$-0.02B |
$0.01B |
357.89% |
| 2024-03-31 |
$-0.02B |
$-0.00B |
237.50% |
| 2023-12-31 |
$-0.01B |
$-0.02B |
152.94% |
| 2023-09-30 |
$-0.01B |
$-0.01B |
144.00% |
| 2023-06-30 |
$-0.01B |
$-0.01B |
209.52% |
| 2023-03-31 |
$-0.01B |
$-0.01B |
250.00% |
| 2022-12-31 |
$-0.01B |
$-0.01B |
440.00% |
| 2022-09-30 |
$-0.01B |
$-0.00B |
4000.00% |
| 2022-06-30 |
$-0.01B |
$-0.00B |
-514.29% |
| 2022-03-31 |
$-0.01B |
$0.00B |
-250.00% |
| 2021-12-31 |
$-0.01B |
$0.00B |
-1000.00% |
| 2021-09-30 |
$-0.01B |
$0.00B |
4400.00% |
| 2021-06-30 |
$-0.01B |
$0.00B |
800.00% |
| 2021-03-31 |
$-0.01B |
$-0.00B |
742.86% |
| 2020-12-31 |
$-0.01B |
$-0.00B |
600.00% |
| 2020-06-30 |
$-0.00B |
$-0.00B |
400.00% |
| 2020-03-31 |
$-0.00B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
